NSEPrice movementRegulatory15 Sept 2026
VARVEE GLOBAL LIMITED
Price movement
Varvee Global Limited has responded to the National Stock Exchange's query regarding significant price movement in its scrip, attributing it to market conditions and stating that the company has made and will continue to make relevant disclosures.
NSECredit RatingRegulatory15 Sept 2026
Balaji Amines Limited
Credit Rating
Balaji Amines Limited has informed the Exchange about the withdrawal of its credit rating by India Ratings and Research due to non-submission of due certificates from banks.
BSECompany UpdateRegulatory15 Sept 2026
Mukta Arts Ltd
Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015
Mukta Arts Ltd has terminated its agreements with Mukta A2 Cinemas Private Limited, Maverick Media Private Limited, and Mr. Rajiv Malhotra due to unresolvable differences between parties.
NSEAction(s) initiated or orders passedRegulatory15 Sept 2026
Interarch Building Solutions Limited
Action(s) initiated or orders passed
Interarch Building Solutions Limited has received a notice from the Income Tax Department under Section 142 of the Income-tax Act, 1961, related to a search and seizure action conducted on August 18, 2025, for the block period 1 April 2019 to 17 October 2025. The notice requires the company to produce accounts and documents and furnish information electronically through the e-Proceedings facility on or before September 29, 2026.
BSECompany UpdateRegulatory15 Sept 2026
Interarch Building Solutions Ltd
Receipt of notice under Section 142(1) of the Income Tax Act, 1961.
Interarch Building Solutions Ltd has received a notice under Section 142(1) of the Income Tax Act, 1961, related to a search and seizure action conducted in August 2025. The notice requires the company to produce accounts and documents and furnish information by September 29, 2026. The company is examining the notice and will file its response within the allowed time.
BSEGeneralRegulatory15 Sept 2026
INTERISE TRUST
INTERISE TRUST has informed the Exchange regarding Disclosure of material issue
Interise Trust has informed the BSE regarding a material issue, specifically a meeting of the Investment and Finance Committee to consider borrowing by way of term loan or issuance of securities.
BSECompany UpdateRegulatory15 Sept 2026
Mukta Arts Limited
Mukta Arts Limited has informed BSE about Intimation on Agreements.
Mukta Arts Limited has informed BSE about Intimation on Agreements.
NSEPrice movementRegulatory15 Sept 2026
Ashoka Metcast Limited
Price movement
The NSE has observed significant price movement in Ashoka Metcast Limited and has written to the company to gather more information.
NSEPrice movementRegulatory15 Sept 2026
VARVEE GLOBAL LIMITED
Price movement
VARVEE GLOBAL LIMITED has observed significant price movement, prompting the NSE to write to the company for clarification, awaiting response.
NSEPrice movementRegulatory15 Sept 2026
ShreeOswal Seeds And Chemicals Limited
Price movement
ShreeOswal Seeds And Chemicals Limited has observed significant price movement, prompting the NSE to write to the company for clarification, awaiting a response.
BSECompany UpdateRegulatory15 Sept 2026
Aurobindo Pharma Ltd
Submission of completion of US FDA inspection of Unit-II of Apitoria Pharma Private Limited, a wholly owned subsidiary of the Company.
Aurobindo Pharma Ltd has informed the exchanges that the US FDA inspection of Unit-II of Apitoria Pharma Private Limited, a wholly owned subsidiary, has concluded with one procedural observation. The company will respond to the US FDA within the stipulated timeline.
BSEInsider Trading / SASTRegulatory15 Sept 2026
KMC Speciality Hospitals (India) Ltd
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 15, 2026 for Sri Kauvery Medical Care (India) Ltd
KMC Speciality Hospitals (India) Ltd has received revised disclosures under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Sri Kauvery Medical Care (India) Ltd regarding discrepancies in the disclosure.
NSEGeneral UpdatesRegulatory15 Sept 2026
Aurobindo Pharma Limited
General Updates
Aurobindo Pharma Limited has informed the Exchange about the completion of a US FDA inspection at its Unit-II of Apitoria Pharma Private Limited, a wholly owned subsidiary, with one procedural observation.
BSECompany UpdateRegulatory15 Sept 2026
Varvee Global Ltd
The Exchange has sought clarification from Varvee Global Ltd on September 15, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.
The BSE has sought clarification from Varvee Global Ltd regarding significant price movement, to ensure investors have relevant information and to safeguard their interests.
BSECompany UpdateRegulatory15 Sept 2026
Ashoka Metcast Ltd
The Exchange has sought clarification from Ashoka Metcast Ltd on September 15, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.
The BSE has sought clarification from Ashoka Metcast Ltd regarding significant price movement, to ensure investors have relevant information and to safeguard their interests.
NSETrading WindowRegulatory15 Sept 2026
Meesho Limited
Trading Window
Meesho Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The Trading Window for dealing in the securities of the Company shall remain closed for all Designated Persons and their Immediate Relatives with effect from Wednesday, September 16, 2026, until the expiry of 48 hours after the declaration of the Unaudited Financial Results.
BSECompany UpdateRegulatory15 Sept 2026
Gala Global Products Ltd
Intimation of the board of directors'' comments on the fine levied by BSE due to non-submission of the shareholding pattern under Regulation 31 of SEBI(LODR)
Gala Global Products Ltd has been fined by BSE for non-submission of shareholding pattern under Regulation 31 of SEBI(LODR). The company has completed the required formalities and is now compliant. The fine of Rs. 96,760 (incl. of 18% GST) is under process of payment.
BSEInsider Trading / SASTRegulatory15 Sept 2026
Indo City Infotech Ltd-$
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Times Growth Securities Ltd
Indo City Infotech Ltd has received a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Times Growth Securities Ltd.
BSECompany UpdateRegulatory15 Sept 2026
Gala Global Products Ltd
Intimation of the board of directors'' comments on the fine levied by the Bombay Stock Exchange for delayed submission of the corporate governance compliance report within the prescribed period under regulation 27(2) of SEBI (LODR)
Gala Global Products Ltd has been fined ₹2,360 by the Bombay Stock Exchange for delayed submission of the corporate governance compliance report within the prescribed period under regulation 27(2) of SEBI (LODR). The company has already paid the fine and has clarified that the delay was unintentional due to administrative and procedural reasons.
BSECompany UpdateRegulatory15 Sept 2026
Gala Global Products Ltd
Intimation of the Board of Directors'' comment on the fine levied by BSE for delay in submission of statement on shareholder complaints within the period prescribed under Regulation 13(3) of SEBI (LODR).
Gala Global Products Ltd has been fined ₹1,180 by BSE for delay in submission of statement on shareholder complaints within the prescribed timeline. The company has already paid the fine and has clarified that the delay was unintentional due to administrative and procedural reasons.